Regionalny Szpital Specjalistyczny Im. Dr. Wladyslawa Bieganskiego — Clinical Trial Site

18 Registered trials

8 Currently recruiting

Organisation

Regionalny Szpital Specjalistyczny Im. Dr. Wladyslawa Bieganskiego

Location

Grudziadz, Poland

Identifier

ORG-100045341

Address

Ul. Dr. Ludwika Rydygiera 15/17, 86-300, Poland

Departments

Clinical Oncology Department
Department of Clinical Oncology
N/A
Oddzial Onkologii Klinicznej
Oddzial rehabilitacji kardiologicznej i kardiologii doswiadczalnej
Oddział Kardiologiczny
Oddział Kardiologii, Kardiologii Inwazyjnej i Elektrofizjologii
Oddział Onkologii Klinicznej
Oddział Rehabilitacji Kardiologicznej i Kardiologii Doświadczalnej
Oncology
Poradnia Onkologiczna

Clinical trials at this site (18)

Search interface

Visugromab in Cachexia International Trial Recruiting

2025-523533-25-00 Cancer-associated Cachexia 10 2026-03-26
Optimal antiplatelet therapy in patients after coronary artery bypass grafting. Recruiting

2025-521892-30-00 Primary isolated CABG patients with stable coronary art 5 2025-11-24
C2321003: A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men with Metastatic Castration-Resistant… Recruiting

2024-511652-40-00 METASTATIC CASTRATION RESISTANT PROSTATE CANCER 5 2025-02-05
Pembrolizumab With or Without Maintenance MK‑2870 in Metastatic Squamous NSCLC Recruiting

2023-510128-66-00 Participants with treatment-naïve metastatic squamous N 5 2024-09-02
A clinical trial comparing a new treatment (MK-5684) to approved medication for advanced prostate cancer after prior hormonal therapy and ch… Recruiting

2023-504899-25-00 Metastatic castration resistant prostate cancer 5 2024-04-04
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) Recruiting

2023-504031-41-00 ER+/HER2- Early Breast Cancer 5 2024-03-25
A clinical study to compare MK-2870 with pembrolizumab to pembrolizumab alone in people with lung cancer (MK-2870-007) Recruiting

2023-503376-24-00 Metastatic non-small cell lung cancer (NSCLC) 5 2024-03-20
Effect of intravenous ferric carboxymaltose on mortality and cardiovascular morbidity, and quality of life in iron deficient patients with r… Recruiting

2024-517206-28-00 Recent myocardial infarction associated with iron defic 6 2022-09-21
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole in People Over 18 Years of Age With HR-Positive, … Ended

2024-512925-95-00 Advanced/Metastatic Breast Cancer 5 2025-05-16
A Study to Learn About the Investigational Medicine Called PF-06821497 (mevrometostat) in Men with mCRPC Who Were Previously Treated with Ab… Ended

2024-511650-50-00 METASTATIC CASTRATION RESISTANT PROSTATE CANCER 5 2025-01-17
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Ended

2022-501024-20-00 ER+/HER2- Early Breast Cancer 5 2023-07-25
An International, Randomized, Double-Blind, Phase III Study of Fuzuloparib Combined with Abiraterone Acetate and Prednisone (AA-P) versus Pl… Ended

2023-509396-16-00 Metastatic Castration-Resistant Prostate Cancer 5 2021-11-08
A phase III multi-center, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as adjuvant trea… Ended

2023-510357-42-00 hormone receptor (HR)-positive, HER2-negative, early br 5 2019-05-22
This is a Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine+Cisplatin for Neoadjuvant Treatmen… Ended

2023-510015-19-00 Patients with histologically or cytologically documente 5 2019-02-11
ARTEMIS: A Phase 3 Study of Ravulizumab to Protect Patients with Chronic Kidney Disease (CKD) from Cardiac Surgery Associated Acute Kidney … Ended

2022-501802-36-00 Prevention of cardiac surgery associated acute kidney i 5 2023-06-16
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF PONSEGROMAB IN PATIENT… Ended

2023-510446-24-00 Cancer cachexia 4 2023-05-30
Evaluation of safety i efficacy de-escalation antiplatelet strategies in acute coronary syndrome. Ended

2024-518090-34-00 Acute Coronary Syndrom (ACS) 5 2022-02-07
A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONS… Ended

2024-512804-20-00 Metastatic Colorectal Cancer 5